Introduction
Only about half of patients with multidrug-resistant TB are cured. Unitaid is investing in developing treatments that are simpler, shorter and less toxic.
Only about half of patients with multidrug-resistant TB are cured. Unitaid is investing in developing treatments that are simpler, shorter and less toxic.